The Association Between Osteocalcin and C-Reactive Protein; A Relation of Bone with Inflammation: A Systematic Review and Meta-Analysis

Abstract

A meta-analysis was performed to summarize the evidence from observational studies regarding the association between serum osteocalcin (OC) and C-reactive protein (CRP). A systemic research of the literature databases including PubMed, SCOPUS, and Google Scholar was performed to identify the relevant studies up to March 2018. We used the random-effects model by the method of DerSimonian and Laird to calculate the overall effect size. Q-test and I ²-statistics were used to assess between-study heterogeneity. In addition, we did subgroup analysis to detect possible sources of heterogeneity based on BMI range, gender, type of study population and age. We identified 21studies of association between serum osteocalcin and CRP eligible for the meta-analysis. The overall effect size showed a significant inverse association between OC and CRP (Fisher’s z=–0.127; 95% CI: –0.166, –0.088, p<0.0001). However, the significant chi-squared statistic result, indicates a heterogeneity of effect sizes (I ²=61.6, df=20, p<0.0001). The subgroup analysis found BMI range, type of study population, and age were the potential sources of heterogeneity. In addition, the strongest correlation was observed in the subgroup of obese subjects (Fisher’s z=–0.264, p=0.002), less than 40 years old (Fisher’s z=–0.115, p<0.0001) and healthy subjects (Fisher’s z=–0.115, p<0.0001). These findings suggest that there is a significant inverse association between serum OC and CRP levels in the adult population.

Key words

osteocalcin - C-reactive protein - meta-analysis

^* These authors (S.F. and E.G.) contributed equally to this work.

• References

• 1 Office of the Surgeon General (US). Bone health and osteoporosis: A report of the Surgeon General. U.S. Department of Health and Human Services. Public Health ServiceOffice of the Surgeon General, Rockville (MD) 2004
• 2 Johnell O, Kanis J. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006; 17: 1726-1733
• 3 Holroyd C, Cooper C, Dennison E. Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab 2008; 22: 671-685
• 4 Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 2006; 194: S3-S11
• 5 Gundberg CM, Lian JB, Gallop PM. et al. Urinary g-carboxyglutamic acid and serum osteocalcin as bone markers: Studies in osteoporosis and Paget’s disease. J Clin Endocrinol Metab 1983; 57: 1221-1225
• 6 Hoang QQ, Sicheri F, Howard AJ. et al. Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature 2003; 425: 977
• 7 Kang AR, Oh YR, Kim HY. et al. Up-regulation of inhibitors of DNA binding/differentiation gene during alendronate-induced osteoblast differentiation. Arch Gynecol Obstet 2012; 285: 1331-1338
• 8 Rosen CJ, Chesnut III CH, Mallinak NJ. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endocrinol Metab 1997; 82: 1904-1910
• 9 Gerdhem P, Ivaska KK, Alatalo SL. et al. Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res 2004; 19: 386-393
• 10 Mera P, Laue K, Ferron M. et al. Osteocalcin signaling in myofibers is necessary and sufficient for optimum adaptation to exercise. Cell Metab 2016; 23: 1078-1092
• 11 Lee NK, Sowa H, Hinoi E. et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007; 130: 456-469
• 12 Oury F, Khrimian L, Denny CA. et al. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell 2013; 155: 228-241
• 13 Confavreux CB, Szulc P, Casey R. et al. Lower serum osteocalcin is associated with more severe metabolic syndrome in elderly men from the MINOS cohort. European. J Endocrinol 2014; 171: 275-283
• 14 Confavreux CB, Szulc P, Casey R. et al. Higher serum osteocalcin is associated with lower abdominal aortic calcification progression and longer 10-year survival in elderly men of the MINOS cohort. J Clin Endocrinol Metab 2013; 98: 1084-1092
• 15 Kindblom JM, Ohlsson C, Ljunggren Ö. et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res 2009; 24: 785-791
• 16 Kanazawa I, Yamaguchi T, Yamauchi M. et al. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int 2011; 22: 187-194
• 17 Hurlimann J, Thorbecke G, Hochwald G. The liver as the site of C-reactive protein formation. J Exp Med 1966; 123: 365-378
• 18 Weinhold B, Rüther U. Interleukin-6-dependent and-independent regulation of the human C-reactive protein gene. Biochem J 1997; 327: 425-429
• 19 Mackiewicz A, Speroff T, Ganapathi MK. et al. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 1991; 146: 3032-3037
• 20 Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 1992; 4: 361-368
• 21 Ferrari S, Ahn-Luong L, Garnero P. et al. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 2003; 88: 255-259
• 22 Eriksson AL, Movérare-Skrtic S, Ljunggren Ö. et al. High-sensitivity CRP is an independent risk factor for all fractures and vertebral fractures in elderly men: The MrOS Sweden study. J Bone Miner Res 2014; 29: 418-423
• 23 Rittayamai N, Chuaychoo B, Sriwijitkamol A. Prevalence of osteoporosis and osteopenia in Thai COPD patients. J Med Assoc Thailand 2012; 95: 1021
• 24 Schaffler A, Muller-Ladner U, Scholmerich J. et al. Role of adipose tissue as an inflammatory organ in human diseases. Endocr Rev 2006; 27: 449-467
• 25 Pittas AG, Harris SS, Eliades M. et al. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 2009; 94: 827-832
• 26 Shea MK, Dallal GE, Dawson-Hughes B. et al. Vitamin K, circulating cytokines, and bone mineral density in older men and women. Am J Clin Nutr 2008; 88: 356-363
• 27 Liao M, Huang L, Mao Y. et al. Serum osteocalcin is associated with inflammatory factors in metabolic syndrome: A population-based study in Chinese males. Mediators Inflamm 2015; 2015: 683739
• 28 Garanty-Bogacka B, Syrenicz M, Rać M. et al. Association between serum osteocalcin, adiposity and metabolic risk in obese children and adolescents. Endokrynol Pol 2013; 64: 346-352
• 29 Lucey AJ, Paschos GK, Thorsdottir I. et al. Young overweight and obese women with lower circulating osteocalcin concentrations exhibit higher insulin resistance and concentrations of C-reactive protein. Nutr Res 2013; 33: 67-75
• 30 Bonneau J, Ferland G, Karelis AD. et al. Association between osteocalcin gamma-carboxylation and insulin resistance in overweight and obese postmenopausal women. J Diabetes Complicat 2017; 31: 1027-1034
• 31 Gu P, Liu Y, Ding Q. et al. Correlation between osteocalcin and visceral fat area in overweight and obese male population. Int J Clin Exp Med 2017; 10: 6980-6986
• 32 Ahn N, Kim K. Effects of 12-week exercise training on osteocalcin, high-sensitivity C-reactive protein concentrations, and insulin resistance in elderly females with osteoporosis. J Phys Ther Sci 2016; 28: 2227-2231
• 33 Fisher RA. Frequency distribution of the values of the correlation coefficient in samples from an indefinitely large population. Biometrika 1915; 10: 507-521
• 34 Higgins J, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558
• 35 DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
• 36 Alissa EM, Alnahdi WA, Alama N. et al. Serum osteocalcin is associated with dietary vitamin D, body weight and serum magnesium in postmenopausal women with and without significant coronary artery disease. Asia Pacific J Clinl Nutr 2014; 23: 246-255
• 37 Chen L, Li Q, Yang Z. et al. Osteocalcin, glucose metabolism, lipid profile and chronic low-grade inflammation in middle-aged and elderly Chinese. Diabetic Med 2013; 30: 309-317
• 38 Polgreen LE, Jacobs DR, Nathan BM. et al. Association of osteocalcin with obesity, insulin resistance, and cardiovascular risk factors in young adults. Obesity 2012; 20: 2194-2201
• 39 Zhang Y, Qi L, Gu W. et al. Relation of serum osteocalcin level to risk of coronary heart disease in Chinese adults. Am J Cardiol 2010; 106: 1461-1465
• 40 Bao Y, Ma X, Yang R. et al. Inverse relationship between serum osteocalcin levels and visceral fat area in Chinese men. J Clin Endocrinol Metab 2013; 98: 345-351
• 41 Bonneau J, Ferland G, Karelis AD. et al. Association between osteocalcin gamma-carboxylation and insulin resistance in overweight and obese postmenopausal women. J Diabetes Complicat 2017; 31: 1027-1034
• 42 Luo Y, Ma X, Hao Y. et al. Association between serum osteocalcin level and visceral obesity in Chinese postmenopausal women. Clin Endocrinol 2015; 83: 429-434
• 43 Lee SW, Jo HH, Kim MR. et al. Association between osteocalcin and metabolic syndrome in postmenopausal women. Arch Gynecol Obstetr 2015; 292: 673-681
• 44 Movahed A, Larijani B, Nabipour I. et al. Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: The crosstalk between bone and energy metabolism. J Bone Mineral Metab 2012; 30: 683-691
• 45 Lee SW, Jo HH, Kim MR. et al. Association between obesity, metabolic risks and serum osteocalcin level in postmenopausal women. Gynecol Endocrinol 2012; 28: 472-477
• 46 Du J, Pan X, Lu Z. et al. Serum osteocalcin levels are inversely associated with the presence of nonalcoholic fatty liver disease in patients with coronary artery disease. Int J Clin Exp Med 2015; 8: 21435-21441
• 47 Bilic-Curcic I, Makarovic S, Mihaljevic I. et al. Bone mineral density in relation to metabolic syndrome components in postmenopausal women with diabetes mellitus type 2. Acta Clin Croat 2017; 56: 58-63
• 48 Sheng L, Cao W, Cha B. et al. Serum osteocalcin level and its association with carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol 2013; 12: 22
• 49 Aoki A, Muneyuki T, Yoshida M. et al. Circulating osteocalcin is increased in early-stage diabetes. Diabetes Res Clin Pract 2011; 92: 181-186
• 50 Pepene CE. Serum under-carboxylated osteocalcin levels in women with polycystic ovary syndrome: Weight-dependent relationships with endocrine and metabolic traits. J Ovarian Res 2013; 6: 4
• 51 Hill H, Grams J, Walton R. et al. Carboxylated and uncarboxylated forms of osteocalcin directly modulate the glucose transport system and inflammation in adipocytes. Horm Metab Res 2014; 46: 341-347
• 52 Ferron M, Hinoi E, Karsenty G. et al. Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A 2008; 105: 5266-5270
• 53 Chen L-l, Li Q, Yang Z. et al. Osteocalcin, glucose metabolism, lipid profile and chronic low-grade inflammation in middle-aged and elderly Chinese. Diabetic Med 2013; 30: 309-317
• 54 Damera S, Raphael KL, Baird BC. et al. Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease. Kidney Int 2011; 79: 228-233
• 55 Filipowicz R, Greene T, Wei G. et al. Associations of serum skeletal alkaline phosphatase with elevated C-reactive protein and mortality. Clin J Am Soc Nephrol 2013; 8: 26-32
• 56 Kunutsor SK, Bakker SJ, Kootstra-Ros JE. et al. Serum alkaline phosphatase and risk of incident cardiovascular disease: Interrelationship with high sensitivity c-reactive protein. PloS One 2015; 10: e0132822
• 57 Wang J, Yan D, Hou X. et al. Association of adiposity indices with bone density and bone turnover in the Chinese population. Osteopor Int 2017; 28: 2645-2652
• 58 Kord-Varkaneh H, Djafarian K, Shab-Bidar S. Association between serum osteocalcin and body mass index: A systematic review and meta-analysis. Endocrine 2017; 58: 24-32
• 59 Knapen MH, Schurgers LJ, Shearer MJ. et al. Association of vitamin K status with adiponectin and body composition in healthy subjects: Uncarboxylated osteocalcin is not associated with fat mass and body weight. Br J Nutr 2012; 108: 1017-1024
• 60 Ferron M, McKee MD, Levine RL. et al. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 2012; 50: 568-575
• 61 Shea MK, Booth SL, Gundberg CM. et al. Adulthood obesity is positively associated with adipose tissue concentrations of vitamin K and inversely associated with circulating indicators of vitamin K status in men and women. J Nutr 2010; 140: 1029-1034
• 62 Wang J, Yan D, Hou X. et al. Association of adiposity indices with bone density and bone turnover in the Chinese population. Osteoporos Int 2017; 28: 2645-2652
• 63 Stulnig TM. Inflammation as a trigger for insulin resistance and cardiometabolic disease. In Morbid Obesity in Adolescents. Berlin: Springer; 2015: 15-20
• 64 Lee D-E, Kehlenbrink S, Lee H. et al. Getting the message across: Mechanisms of physiological cross talk by adipose tissue. Am J Physiol Endocrinol Metab 2009; 296: E1210-E1229
• 65 Xu H, Barnes GT, Yang Q. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Eur J Clin Invest 2003; 112: 1821
• 66 Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96: 939-949
• 67 Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860
• 68 Darwish L, Nguyen M, Saleem M. et al. Lower serum osteocalcin concentrations in patients with type 2 diabetes and relationships with vascular risk factors among patients with coronary artery disease. J Diabetes Complicat 2019; 33: 390-397
• 69 Zhang X-l, Shen Y, Ma X-j. et al. Low serum osteocalcin levels are correlated with left ventricular systolic dysfunction and cardiac death in Chinese men. Acta Pharmacol Sinica 2018; 40: 486-491
• 70 Gevers G, Devos P, De Roo M. et al. Increased levels of osteocalcin (serum bone Gla-protein) in rheumatoid arthritis. Br J Rheumatol 1986; 25: 260-262